Ligand-Dependent Conformations and Dynamics of the Serotonin 5-HT2A Receptor Determine Its Activation and Membrane-Driven Oligomerization Properties
暂无分享,去创建一个
George Khelashvili | Jufang Shan | Harel Weinstein | Ernest L. Mehler | Sayan Mondal | H. Weinstein | E. Mehler | G. Khelashvili | Sayantan Mondal | Jufang Shan
[1] Graeme Milligan,et al. Identification of a serotonin/glutamate receptor complex implicated in psychosis , 2008, Nature.
[2] S. Sealfon,et al. Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex , 2003, The Journal of Neuroscience.
[3] Arthur Christopoulos,et al. A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity , 2008, Journal of Biological Chemistry.
[4] osé Morenoa,et al. etabotropic glutamate mGlu 2 receptor is necessary for the pharmacological nd behavioral effects induced by hallucinogenic 5-HT 2 A receptor agonists , 2011 .
[5] H. Weinstein,et al. Active State-like Conformational Elements in the β2-AR and a Photoactivated Intermediate of Rhodopsin Identified by Dynamic Properties of GPCRs† , 2008, Biochemistry.
[6] C. Nichols. Serotonin 5-HT2A Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases , 2009, Cardiovascular psychiatry and neurology.
[7] B. Roth,et al. Arresting serotonin , 2008, Proceedings of the National Academy of Sciences.
[8] W. Weis,et al. Structural insights into G-protein-coupled receptor activation. , 2008, Current opinion in structural biology.
[9] D S Goodsell,et al. Automated docking of flexible ligands: Applications of autodock , 1996, Journal of molecular recognition : JMR.
[10] R. Stevens,et al. The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.
[11] S. W. Lin,et al. Specific tryptophan UV-absorbance changes are probes of the transition of rhodopsin to its active state. , 1996, Biochemistry.
[12] George Khelashvili,et al. GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge Base , 2010, Bioinform..
[13] R. Friesner,et al. Novel procedure for modeling ligand/receptor induced fit effects. , 2006, Journal of medicinal chemistry.
[14] E. sanders-Bush,et al. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors , 2002, Neuroscience.
[15] Davide Provasi,et al. Ligand-Induced Modulation of the Free-Energy Landscape of G Protein-Coupled Receptors Explored by Adaptive Biasing Techniques , 2011, PLoS Comput. Biol..
[16] Harel Weinstein,et al. Conserved Helix 7 Tyrosine Acts as a Multistate Conformational Switch in the 5HT2C Receptor , 2002, The Journal of Biological Chemistry.
[17] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[18] L. Luttrell,et al. Refining efficacy: exploiting functional selectivity for drug discovery. , 2011, Advances in pharmacology.
[19] J. Ramachandran,et al. Structure and Function of G Protein Coupled Receptors , 1990, Pharmaceutical Research.
[20] Terry Kenakin,et al. Ligand-selective receptor conformations revisited: the promise and the problem. , 2003, Trends in pharmacological sciences.
[21] Harel Weinstein,et al. The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site. , 2008, Molecular cell.
[22] R. Seifert,et al. Functional Selectivity of GPCR Ligand Stereoisomers: New Pharmacological Opportunities , 2009, Molecular Pharmacology.
[23] H Weinstein,et al. Mapping the Binding Site Pocket of the Serotonin 5-Hydroxytryptamine2A Receptor , 1996, The Journal of Biological Chemistry.
[24] S. Rasmussen,et al. Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.
[25] M. Jochum,et al. Helix 8 Plays a Crucial Role in Bradykinin B2 Receptor Trafficking and Signaling , 2011, The Journal of Biological Chemistry.
[26] J. González-Maeso. Anxious interactions , 2010, Nature Neuroscience.
[27] S. Feller,et al. Molecular simulations and solid-state NMR investigate dynamical structure in rhodopsin activation. , 2012, Biochimica et biophysica acta.
[28] Krzysztof Palczewski,et al. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin , 2006, Proceedings of the National Academy of Sciences.
[29] D. C. Mitchell,et al. Regulation of membrane proteins by dietary lipids: effects of cholesterol and docosahexaenoic acid acyl chain-containing phospholipids on rhodopsin stability and function. , 2008, Biophysical journal.
[30] P. Sexton,et al. Determination of Adenosine A1 Receptor Agonist and Antagonist Pharmacology Using Saccharomyces cerevisiae: Implications for Ligand Screening and Functional Selectivity , 2009, Journal of Pharmacology and Experimental Therapeutics.
[31] H. Lester,et al. The role of conserved aspartate and serine residues in ligand binding and in function of the 5‐HT1A receptor: A site‐directed mutation study , 1992, FEBS letters.
[32] J. Ballesteros,et al. Structural motifs as functional microdomains in G-protein-coupled receptors: Energetic considerations in the mechanism of activation of the serotonin 5-HT2A receptor by disruption of the ionic lock of the arginine cage* , 2002 .
[33] H Weinstein,et al. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus. , 1996, Molecular pharmacology.
[34] D C Teller,et al. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). , 2001, Biochemistry.
[35] H. Khorana,et al. Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.
[36] S. Rasmussen,et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.
[37] Harel Weinstein,et al. A flexible docking procedure for the exploration of peptide binding selectivity to known structures and homology models of PDZ domains. , 2005, Journal of the American Chemical Society.
[38] Wayne A Hendrickson,et al. Ligand sensitivity in dimeric associations of the serotonin 5HT2c receptor , 2008, EMBO reports.
[39] H. Khorana,et al. Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. , 1996, Biochemistry.
[40] Tod D Romo,et al. Concerted interconversion between ionic lock substates of the beta(2) adrenergic receptor revealed by microsecond timescale molecular dynamics. , 2010, Biophysical journal.
[41] Laxmikant V. Kalé,et al. Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..
[42] Jianpeng Ma,et al. CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..
[43] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[44] B. Kobilka. G protein coupled receptor structure and activation. , 2007, Biochimica et biophysica acta.
[45] P Ghanouni,et al. Agonist-induced conformational changes in the G-protein-coupling domain of the β2 adrenergic receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[46] George Khelashvili,et al. Quantitative modeling of membrane deformations by multihelical membrane proteins: application to G-protein coupled receptors. , 2011, Biophysical journal.
[47] B. Roux,et al. Absolute binding free energy calculations of sparsomycin analogs to the bacterial ribosome. , 2010, The journal of physical chemistry. B.
[48] Javier González-Maeso,et al. Agonist-trafficking and hallucinogens. , 2009, Current medicinal chemistry.
[49] Alexander D. MacKerell,et al. Extending the treatment of backbone energetics in protein force fields: Limitations of gas‐phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations , 2004, J. Comput. Chem..
[50] B. Roth,et al. Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors. , 1997, Molecular pharmacology.
[51] P. Kollman,et al. A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .
[52] Harel Weinstein,et al. Three-dimensional representations of G protein-coupled receptor structures and mechanisms. , 2002, Methods in enzymology.
[53] A. Poso,et al. A Proton Relay Process as the Mechanism of Activation of the Histamine H3-Receptor Determined by 1H NMR and ab Initio Quantum Mechanical Calculations , 2000 .
[54] T. Darden,et al. A smooth particle mesh Ewald method , 1995 .
[55] E. Hermans,et al. Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities. , 2010, Biochemical pharmacology.
[56] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[57] Michael J. Crawley,et al. The R book , 2022 .
[58] H Weinstein,et al. Theoretical studies on the activation mechanism of the histamine H2-receptor: the proton transfer between histamine and a receptor model. , 1986, Molecular pharmacology.
[59] C. Altenbach,et al. High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation , 2008, Proceedings of the National Academy of Sciences.
[60] Michael R. Braden,et al. Assessment of the Roles of Serines 5.43(239) and 5.46(242) for Binding and Potency of Agonist Ligands at the Human Serotonin 5-HT2A Receptor , 2007, Molecular Pharmacology.
[61] Arthur Christopoulos,et al. Functional Selectivity and Classical Concepts of Quantitative Pharmacology , 2007, Journal of Pharmacology and Experimental Therapeutics.
[62] Vadim Cherezov,et al. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. , 2008, Structure.
[63] P. Sexton,et al. Detection of novel functional selectivity at M3 muscarinic acetylcholine receptors using a Saccharomyces cerevisiae platform. , 2010, ACS chemical biology.
[64] R. Levenson,et al. Ligand-Directed Functional Selectivity at the Mu Opioid Receptor Revealed by Label-Free Integrative Pharmacology On-Target , 2011, PloS one.
[65] N. Heveker,et al. Functional Selectivity of Natural and Synthetic Prostaglandin EP4 Receptor Ligands , 2009, Journal of Pharmacology and Experimental Therapeutics.
[66] Leonardo Pardo,et al. Ligand-regulated oligomerization of β2-adrenoceptors in a model lipid bilayer , 2009, The EMBO journal.
[67] K. Hideg,et al. Photoactivated conformational changes in rhodopsin: a time-resolved spin label study. , 1993, Science.
[68] B. Roth,et al. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism. , 2000, The Journal of pharmacology and experimental therapeutics.
[69] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[70] Oliver P. Ernst,et al. Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.
[71] Sandhya Kortagere,et al. Ab initio computational modeling of long loops in G-protein coupled receptors , 2006, J. Comput. Aided Mol. Des..
[72] Thomas Huber,et al. G protein-coupled receptors self-assemble in dynamics simulations of model bilayers. , 2007, Journal of the American Chemical Society.
[73] Clay W Scott,et al. Evaluating Cellular Impedance Assays for Detection of GPCR Pleiotropic Signaling and Functional Selectivity , 2009, Journal of biomolecular screening.
[74] Xavier Deupi,et al. Coupling ligand structure to specific conformational switches in the β2-adrenoceptor , 2006, Nature chemical biology.
[75] J. Javitch,et al. CODA-RET reveals functional selectivity as a result of GPCR heteromerization , 2011, Nature chemical biology.
[76] George Khelashvili,et al. Structural and dynamic effects of cholesterol at preferred sites of interaction with rhodopsin identified from microsecond length molecular dynamics simulations , 2009, Proteins.
[77] Harel Weinstein,et al. Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G protein-coupled receptors , 2005, The AAPS Journal.
[78] Patrick Scheerer,et al. Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.
[79] T. Schwartz,et al. Molecular mechanism of 7TM receptor activation--a global toggle switch model. , 2006, Annual review of pharmacology and toxicology.
[80] Xavier Deupi,et al. Activation of G protein-coupled receptors. , 2007, Advances in protein chemistry.
[81] Thomas L. James,et al. Docking to RNA via Root-Mean-Square-Deviation-Driven Energy Minimization with Flexible Ligands and Flexible Targets , 2008, J. Chem. Inf. Model..
[82] Terry Kenakin. Functional selectivity in GPCR modulator screening. , 2008, Combinatorial chemistry & high throughput screening.
[83] O. Andersen,et al. Hydrophobic Coupling of Lipid Bilayer Energetics to Channel Function , 2003, The Journal of general physiology.
[84] Mark S.P. Sansom,et al. Hinges, swivels and switches: the role of prolines in signalling via transmembrane α-helices , 2000 .
[85] H. Weinstein,et al. The binding sites for cocaine and dopamine in the dopamine transporter overlap , 2008, Nature Neuroscience.
[86] MC-PHS: a Monte Carlo implementation of the primary hydration shell for protein folding and design. , 2003, Biophysical journal.
[87] K. Palczewski,et al. Role of membrane integrity on G protein-coupled receptors: Rhodopsin stability and function. , 2011, Progress in lipid research.
[88] H. Weinstein,et al. Molecular basis of partial agonism: orientation of indoleamine ligands in the binding pocket of the human serotonin 5-HT2A receptor determines relative efficacy. , 2003, Molecular Pharmacology.
[89] T. Kenakin,et al. Refining efficacy: allosterism and bias in G protein-coupled receptor signaling. , 2011, Methods in molecular biology.
[90] Gebhard F. X. Schertler,et al. Two distinct conformations of helix 6 observed in antagonist-bound structures of a β1-adrenergic receptor , 2011, Proceedings of the National Academy of Sciences.
[91] Berk Hess,et al. GROMACS 3.0: a package for molecular simulation and trajectory analysis , 2001 .
[92] Tsutomu Kouyama,et al. Crystal structure of squid rhodopsin , 2008, Nature.
[93] Kunhong Xiao,et al. Multiple ligand-specific conformations of the β2-adrenergic receptor. , 2011, Nature chemical biology.
[94] Manfred Burghammer,et al. Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.
[95] D. C. Mitchell,et al. Optimization of Receptor-G Protein Coupling by Bilayer Lipid Composition I , 2001, The Journal of Biological Chemistry.
[96] Ron O Dror,et al. Identification of two distinct inactive conformations of the β2-adrenergic receptor reconciles structural and biochemical observations , 2009, Proceedings of the National Academy of Sciences.
[97] T. Gallaher,et al. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation. , 1993, Molecular pharmacology.
[98] Marta Filizola,et al. Dynamic models of G-protein coupled receptor dimers: indications of asymmetry in the rhodopsin dimer from molecular dynamics simulations in a POPC bilayer , 2006, J. Comput. Aided Mol. Des..
[99] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[100] S. Sealfon,et al. Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists , 2011, Neuroscience Letters.
[101] G. Milligan,et al. Selectivity and functional consequences of interactions of family A G protein‐coupled receptors with neurochondrin and periplakin , 2009, Journal of neurochemistry.
[102] R. Mailman. GPCR functional selectivity has therapeutic impact. , 2007, Trends in pharmacological sciences.
[103] Tod D Romo,et al. A Lipid Pathway for Ligand Binding Is Necessary for a Cannabinoid G Protein-coupled Receptor* , 2010, The Journal of Biological Chemistry.
[104] Mihaly Mezei,et al. Simulaid: A simulation facilitator and analysis program , 2010, J. Comput. Chem..
[105] Robert P. Millar,et al. Functional Microdomains in G-protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[106] K. Palczewski,et al. Activation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes. , 2008, Annual review of pharmacology and toxicology.
[107] H. Weinstein,et al. Hinges, swivels and switches: the role of prolines in signalling via transmembrane alpha-helices. , 2000, Trends in pharmacological sciences.
[108] M. Maeda,et al. FRET-based monitoring of conformational change of the beta2 adrenergic receptor in living cells. , 2006, Biochemical and biophysical research communications.
[109] U. Gether. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.
[110] G. Voth,et al. A role for a specific cholesterol interaction in stabilizing the Apo configuration of the human A(2A) adenosine receptor. , 2009, Structure.
[111] H Weinstein,et al. Prokink: a protocol for numerical evaluation of helix distortions by proline. , 2000, Protein engineering.
[112] Harel Weinstein,et al. Towards a quantitative representation of the cell signaling mechanisms of hallucinogens: Measurement and mathematical modeling of 5-HT1A and 5-HT2A receptor-mediated ERK1/2 activation , 2009, Neuropharmacology.
[113] Marta Filizola,et al. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[114] P. Kollman,et al. Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.
[115] Sergio A Hassan,et al. Ab initio computational modeling of loops in G‐protein‐coupled receptors: Lessons from the crystal structure of rhodopsin , 2006, Proteins.
[116] G Vriend,et al. The essential dynamics of thermolysin: Confirmation of the hinge‐bending motion and comparison of simulations in vacuum and water , 1995, Proteins.
[117] H. Weinstein,et al. Constitutive activation of the mu opioid receptor by mutation of D3.49(164), but not D3.32(147): D3.49(164) is critical for stabilization of the inactive form of the receptor and for its expression. , 2001, Biochemistry.
[118] H. Weinstein,et al. The Substrate-Driven Transition to an Inward-Facing Conformation in the Functional Mechanism of the Dopamine Transporter , 2011, PloS one.
[119] Thomas Huber,et al. Curvature and hydrophobic forces drive oligomerization and modulate activity of rhodopsin in membranes. , 2006, Biophysical journal.
[120] H. Weinstein,et al. Probing the structural determinants for the function of intracellular loop 2 in structurally cognate G-protein-coupled receptors. , 2010, Biochemistry.
[121] K. Fahmy,et al. Transducin-dependent protonation of glutamic acid 134 in rhodopsin. , 2000, Biochemistry.